I would think that Teva should get ready to be disappointed. The one main thing I know about Pharma investing is if you're depending on the FDA to do something 99% of the time you'll be disappointed.
Secondly, unless Teva followed the same recipe for approval as Momenta did (and they didn't or they'd be approved) I see no reason of why the FDA would deviate from its detailed reply to Sanofi until the Sanofi/FDA lawsuits are settled.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.